Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Chronic Rhinosinusitis With Nasal Polyps
NCT05143502Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Jan 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of montelukast in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Assiut University. Primary endpoint: Change at nasal polyp size at 12 weeks. Status: unknown.
02
Drugs
montelukast
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05143502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05143502.